Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
Go back to Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes| TANDEM DIABETES (NASDAQ: TNDM) | Delayed: 14.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.34 | 52 Week High | $12.48 | |||
| Open | $14.34 | 52 Week Low | $1.60 | |||
| Day High | $14.34 | P/E | N/A | |||
| Day Low | $14.34 | EPS | $-6.33 | |||
| Volume | 2,211 | |||||

